Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. (Q41650958)
Jump to navigation
Jump to search
scientific article published on February 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. |
scientific article published on February 1997 |
Statements
Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients (English)
1 February 1997